Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 44,636,031
- Share change
- +4,371,968
- Total reported value
- $371,816,808
- Put/Call ratio
- 14%
- Price per share
- $8.33
- Number of holders
- 97
- Value change
- +$35,289,257
- Number of buys
- 40
- Number of sells
- 55
Report period
Q1 2023
Institutions
97
Top holders
10
STOK full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Skorpios Trust |
13F
|
Company |
25%
|
14,443,681
|
$133,315,000 | — | 31 Dec 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
6.6%
|
3,870,981
|
$35,729,155 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
5.2%
|
3,034,649
|
$28,009,810 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
4.2%
|
2,453,686
|
$22,647,523 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
1,830,647
|
$16,896,872 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
1,602,045
|
$14,786,876 | — | 31 Dec 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.9%
|
1,108,913
|
$10,235,267 | — | 31 Dec 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.8%
|
1,087,807
|
$10,040,000 | — | 31 Dec 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.3%
|
763,456
|
$7,046,699 | — | 31 Dec 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1.3%
|
748,077
|
$6,904,750 | — | 31 Dec 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
747,786
|
$6,902,065 | — | 31 Dec 2022 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
642,430
|
$5,929,629 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
612,054
|
$5,649,259 | — | 31 Dec 2022 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.94%
|
550,219
|
$5,078,521 | — | 31 Dec 2022 | |
| M28 Capital Management LP |
13F
|
Company |
0.82%
|
482,890
|
$4,457,075 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
474,224
|
$4,377,000 | — | 31 Dec 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.73%
|
428,200
|
$3,952,286 | — | 31 Dec 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.73%
|
427,888
|
$3,962,243 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.71%
|
419,179
|
$3,869,000 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.7%
|
413,749
|
$3,818,903 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.67%
|
395,107
|
$3,647,000 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.67%
|
394,312
|
$3,639,500 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
309,506
|
$2,856,741 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.5%
|
292,007
|
$2,695,000 | — | 31 Dec 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.43%
|
250,000
|
$2,308,000 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
198,516
|
$1,832,303 | — | 31 Dec 2022 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.32%
|
188,640
|
$1,741,147 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
164,862
|
$1,521,676 | — | 31 Dec 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.18%
|
108,282
|
$999,000 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
104,600
|
$965,000 | — | 31 Dec 2022 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.16%
|
91,615
|
$845,607 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
90,775
|
$837,853 | — | 31 Dec 2022 | |
| Trexquant Investment LP |
13F
|
Company |
0.15%
|
87,529
|
$807,893 | — | 31 Dec 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.13%
|
77,194
|
$711,000 | — | 31 Dec 2022 | |
| Fort Point Capital Partners LLC |
13F
|
Company |
0.13%
|
75,429
|
$696,210 | — | 31 Dec 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.12%
|
71,572
|
$661,000 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.12%
|
68,835
|
$635,347 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
67,862
|
$626,367 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
62,584
|
$578,000 | — | 31 Dec 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.1%
|
56,125
|
$518,034 | — | 31 Dec 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
48,976
|
$452,048 | — | 31 Dec 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.08%
|
45,152
|
$409,997 | — | 31 Dec 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.08%
|
44,345
|
$409,304 | — | 31 Dec 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.07%
|
40,462
|
$373,464 | — | 31 Dec 2022 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
40,413
|
$373,012 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
37,200
|
$343,356 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
36,600
|
$337,818 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
34,493
|
$319,000 | — | 31 Dec 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
34,191
|
$316,000 | — | 31 Dec 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
31,564
|
$291,336 | — | 31 Dec 2022 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q1 2023
As of 31 Mar 2023,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,636,031 shares.
The largest 10 holders included
Skorpios Trust, RTW INVESTMENTS, LP, Redmile Group, LLC, COWEN AND COMPANY, LLC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, and Cormorant Asset Management, LP.
This page lists
97
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
106
Q1 2023 holders
97
Holder diff
-9
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.